Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients

Clinical trial NCT03776123 · COMPLETED

Trial details

NCT number: NCT03776123
Sponsor: Ipsen
Status: COMPLETED
Study type: OBSERVATIONAL

Renal Cell Carcinoma Hepatocellular Carcinoma Differentiated Thyroid Carcinoma

Start date: 2019-05-15
Primary completion: 2024-03-26
Enrollment: 347

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.